Concepedia

Author

V. Bramwell

BC Cancer Agency

Also Known As

M. Levine, V Bramwell, V H Bramwell, V. Bramwell, V. H. Bramwell, V. H. C. Bramwell, V.H.C Bramwell, V.H.C. Bramwell, VHC Bramwell, Vivien H.C. Bramwell

77

Publications

4.6K

Citations

30

H-Index

57

Concepts

All Affiliations

BC Cancer AgencyEuropean Organisation for Research and Treatment of CancerSunnybrook Health Science CentreOttawa Regional Cancer FoundationJuravinski Cancer Centre
VB

About

V. Bramwell is an author at BC Cancer Agency specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

33

2.1K

2

Health Sciences

8

8

449

3

Engineering

1

1

30

4

Nursing

1

1

225

5

Cell Biology

1

1

48

V. Bramwell

×

44

Publications

3.9K

Citations

29

H-Index

YearCitations

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard,

Journal of Clinical Oncology

1998

622

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

E. Gortzak, Alberto Azzarelli, J. Buesa,

European Journal of Cancer

2001

376

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.

V. Bramwell, M Burgers, R. S. Sneath,

Journal of Clinical Oncology

1992

315

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

V. Bramwell, Jacques Rouëssé, William P. Steward,

Journal of Clinical Oncology

1994

249

Quality of life in stage II breast cancer: an instrument for clinical trials.

Mark N. Levine, Gordon Guyatt, Michael Gent,

Journal of Clinical Oncology

1988

225

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Jeremy Whelan, Rachel C. Jinks, Anne McTiernan,

Annals of Oncology

2011

201

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

F P O’Malley, Stephen Chia, Dongsheng Tu,

JNCI Journal of the National Cancer Institute

2009

194

STEROID-HORMONE RECEPTORS AND SURVIVAL AFTER FIRST RELAPSE IN BREAST CANCER

Anthony Howell, R.N.L. Harland, V. Bramwell,

The Lancet

1984

176

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

Henning T. Mouridsen, Lars Bastholt, R. Somers,

European Journal of Cancer and Clinical Oncology

1987

154

Cyvadic in advanced soft tissue sarcoma: A randomized study comparing two schedules: A study of the EORTC soft tissue and bone sarcoma group

Herbert M. Pinedo, V. Bramwell, Henning T. Mouridsen,

Cancer

1984

128

Page 1